ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,321 | +288.9% | 924 | +645.2% | 0.00% | – |
| Q2 2023 | $2,654 | -82.0% | 124 | -65.9% | 0.00% | – |
| Q1 2023 | $14,720 | -14.7% | 364 | -1.9% | 0.00% | – |
| Q4 2022 | $17,259 | -13.7% | 371 | -4.9% | 0.00% | – |
| Q3 2022 | $20,000 | +25.0% | 390 | +13.4% | 0.00% | – |
| Q2 2022 | $16,000 | +23.1% | 344 | +84.9% | 0.00% | – |
| Q1 2022 | $13,000 | 0.0% | 186 | +6.3% | 0.00% | – |
| Q4 2021 | $13,000 | +62.5% | 175 | +18.2% | 0.00% | – |
| Q3 2021 | $8,000 | -82.2% | 148 | -85.4% | 0.00% | – |
| Q2 2021 | $45,000 | -22.4% | 1,017 | -14.2% | 0.00% | – |
| Q1 2021 | $58,000 | +41.5% | 1,185 | +21.3% | 0.00% | – |
| Q4 2020 | $41,000 | +485.7% | 977 | +518.4% | 0.00% | – |
| Q3 2020 | $7,000 | 0.0% | 158 | +17.0% | 0.00% | – |
| Q2 2020 | $7,000 | -36.4% | 135 | -39.2% | 0.00% | – |
| Q1 2020 | $11,000 | -21.4% | 222 | 0.0% | 0.00% | – |
| Q4 2019 | $14,000 | +7.7% | 222 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | -31.6% | 222 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | -20.8% | 222 | -11.9% | 0.00% | – |
| Q1 2019 | $24,000 | +50.0% | 252 | +13.5% | 0.00% | – |
| Q4 2018 | $16,000 | -40.7% | 222 | -29.5% | 0.00% | – |
| Q3 2018 | $27,000 | -30.8% | 315 | -7.1% | 0.00% | – |
| Q2 2018 | $39,000 | +44.4% | 339 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | +35.0% | 339 | 0.0% | 0.00% | – |
| Q4 2017 | $20,000 | +25.0% | 339 | 0.0% | 0.00% | – |
| Q3 2017 | $16,000 | -77.1% | 339 | -82.5% | 0.00% | – |
| Q2 2017 | $70,000 | +16.7% | 1,942 | 0.0% | 0.00% | – |
| Q1 2017 | $60,000 | -20.0% | 1,942 | -12.7% | 0.00% | – |
| Q4 2016 | $75,000 | +27.1% | 2,224 | 0.0% | 0.00% | – |
| Q3 2016 | $59,000 | -50.8% | 2,224 | -58.9% | 0.00% | – |
| Q2 2016 | $120,000 | -32.6% | 5,408 | -10.4% | 0.00% | -100.0% |
| Q1 2016 | $178,000 | +17.1% | 6,039 | +31.3% | 0.00% | 0.0% |
| Q4 2015 | $152,000 | -38.2% | 4,598 | -32.4% | 0.00% | 0.0% |
| Q3 2015 | $246,000 | -29.7% | 6,801 | -12.7% | 0.00% | 0.0% |
| Q2 2015 | $350,000 | +21.1% | 7,786 | -17.5% | 0.00% | 0.0% |
| Q1 2015 | $289,000 | -74.2% | 9,440 | -57.1% | 0.00% | -75.0% |
| Q4 2014 | $1,119,000 | +97.7% | 22,007 | +53.7% | 0.00% | +100.0% |
| Q3 2014 | $566,000 | +54.6% | 14,318 | +68.4% | 0.00% | +100.0% |
| Q2 2014 | $366,000 | – | 8,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |